ovamed page header

OvaMed Study

Comparison of Regu-Mate® & OvaMed® for Suppression of estrus in mares*

Edward L Squires, MS, PhD, ACT (hon) Reproductive Management, Ft Collins CO
Molly Spooner, DVM Vista Equine, Windsor Colorado
Jake Dahl, BS Vista Equine, Windsor Colorado

protaglandinTwenty-four, non-lactating mares were randomly assigned to 1 of 3 groups: untreated controls; Regu-Mate® 10 mL orally, and OvaMed® 10 mL orally. Treatment was given daily for 10 days.

There was no difference in the number of days to ovulation between the Regu-Mate® and the OvaMed® groups, and both groups were different (P<0.05) from the untreated controls.

OvaMed® and Regu-Mate® provide the same response by delaying estrus and ovulation after prostaglandin injection.

*Data on file

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
WARNINGS: Not for use in humans. For oral use in horses only. Keep this and all other medications out of the reach of children. Do not use in horses intended for human consumption.
HUMAN WARNINGS: Skin contact must be avoided as OvaMed® Solution 0.22% is readily absorbed through unbroken skin. Protective gloves must be worn by all persons handling this product. Pregnant women or women who suspect they are pregnant should not handle OvaMed® Solution 0.22%. Women of childbearing age should exercise extreme caution when handling this product. Accidental absorption could lead to a disruption of the menstrual cycle or prolongation of pregnancy. Direct contact with the skin should therefore be avoided. Accidental spillage on the skin should be washed off immediately with soap and water.

Contact Us - US

Bimeda® US - Head Office
One Tower Lane, Suite 2250,
Oakbrook Terrace, IL 60181
Phone: 1 888 524 6332